Ligand Binding to the (1 → 3)-β-D-Glucan Receptor Stimulates NFκB Activation, but Not Apoptosis in U937 Cells

Recent data suggest that sepsis stimulates macrophage apoptosis (Ao) with subsequent induction of macrophage dysfunction. Nuclear factor-kappaB (NFkappaB) activation has been linked to Ao in either a pro- or antiapoptotic role. Glucans are biological response modifiers which exert antisepsis activity. This investigation examined the effect of (1-3)-beta-D-glucan receptor binding by a high affinity ligand on Ao and NFkappaB activation in U937 cells in the presence or absence of LPS. A high affinity glucan ligand (IC50 = 23 nM) activated NFkappaB, but did not induce Ao or significantly alter LPS induced U937 Ao. These data indicate that: i) modulation of the macrophage (1-3)-beta-D-glucan receptor stimulates NFkappaB; ii) does not induce Ao or significantly diminish LPS induced Ao and iii) activation of the U937 FAS receptor does not alter the relative Ao responses in glucan and LPS treated cells.

[1]  J. Heesemann,et al.  Yersinia enterocolitica Impairs Activation of Transcription Factor NF-κB: Involvement in the Induction of Programmed Cell Death and in the Suppression of the Macrophage Tumor Necrosis Factor α Production , 1998, The Journal of experimental medicine.

[2]  D. Brenner,et al.  NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. , 1998, The Journal of clinical investigation.

[3]  S. Pero,et al.  PGG‐Glucan activates NF‐κB‐like and NF‐IL‐6‐like transcription factor complexes in a murine monocytic cell line , 1997, Journal of leukocyte biology.

[4]  D. Männel,et al.  Role of NFkappaB in the mortality of sepsis. , 1997, The Journal of clinical investigation.

[5]  S. Orrenius,et al.  Induction of apoptosis and potentiation of TNF- and Fas-mediated apoptosis in U937 cells by the xanthogenate compound D609. , 1997, Experimental cell research.

[6]  A. Ayala.  Lymphoid apoptosis during sepsis: now that we've found it, what do we do with it? , 1997, Critical care medicine.

[7]  I. Chaudry,et al.  Factors responsible for peritoneal granulocyte apoptosis during sepsis. , 1997, The Journal of surgical research.

[8]  Marty W. Mayo,et al.  TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.

[9]  J. Orenstein,et al.  Fas mediates apoptosis in human monocytes by a reactive oxygen intermediate dependent pathway. , 1996, Journal of immunology.

[10]  David L. Williams,et al.  Receptor binding and internalization of a water-soluble (1-->3)-beta-D-glucan biologic response modifier in two monocyte/macrophage cell lines. , 1996, Journal of immunology.

[11]  I. Chaudry,et al.  Is sepsis-induced apoptosis associated with macrophage dysfunction? , 1996, The Journal of trauma.

[12]  V. Vetvicka,et al.  Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). , 1996, Journal of immunology.

[13]  W. Browder,et al.  Preclinical and clinical evaluation of carbohydrate immunopharmaceuticals in the prevention of sepsis and septic sequelae , 1995 .

[14]  E. Jones,et al.  Comparison of the carbohydrate biological response modifiers Krestin, schizophyllan and glucan phosphate by aqueous size exclusion chromatography with in-line argon-ion multi-angle laser light scattering photometry and differential viscometry detectors. , 1995, Journal of chromatography. B, Biomedical applications.

[15]  T. Babineau,et al.  Randomized Phase I/II Trial of a Macrophage‐Specific Immunomodulator (PGG‐Glucan) in High‐Risk Surgical Patients , 1994, Annals of surgery.

[16]  T. Babineau,et al.  A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients. , 1994, Archives of surgery.

[17]  E. Jones,et al.  NMR spectral analysis of a water-insoluble (1-->3)-beta-D-glucan isolated from Saccharomyces cerevisiae. , 1994, Carbohydrate research.

[18]  T. Blemmer,et al.  Enantioselective high-performance liquid chromatographic method for the determination of methadone in serum using an AGP and a CN column as chiral and analytical column, respectively. , 1994, Journal of chromatography. A.

[19]  Mendes Nf,et al.  Infection prevention in patients with severe multiple trauma with the immunomodulator beta 1-3 polyglucose (glucan). , 1993 .

[20]  G. Ostroff,et al.  Anti-infective effect of poly-beta 1-6-glucotriosyl-beta 1-3-glucopyranose glucan in vivo , 1992, Infection and immunity.

[21]  E. Jones,et al.  A method for the solubilization of a (1----3)-beta-D-glucan isolated from Saccharomyces cerevisiae. , 1991, Carbohydrate research.

[22]  H. Ensley,et al.  Isolation, physicochemical characterization and preclinical efficacy evaluation of soluble scleroglucan. , 1991, The Journal of pharmacology and experimental therapeutics.

[23]  L. Rasmussen,et al.  Dynamics of blood components and peritoneal fluid during treatment of murine E. coli sepsis with beta-1,3-D-polyglucose derivatives. II. Interleukin 1, tumour necrosis factor, prostaglandin E2, and leukotriene B4. , 1990, Scandinavian journal of immunology.

[24]  L. Rasmussen,et al.  Dynamics of Blood Components and Peritoneal Fluid during Treatment of Murine E. coli Sepsis with β‐1, 3‐D‐Polyglucose Derivatives , 1990 .

[25]  D. Williams,et al.  Beneficial effect of enhanced macrophage function in the trauma patient. , 1990, Annals of surgery.

[26]  D. Williams,et al.  Immunotherapeutic modification of Escherichia coli--induced experimental peritonitis and bacteremia by glucan. , 1983, Surgery.

[27]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .

[28]  D. Williams,et al.  Effect of glucan on neutrophil dynamics and immune function in Escherichia coli peritonitis. , 1988, The Journal of surgical research.